Drugs / ASTX029-01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06113289 | Feb 2024 → Mar 2025 | acute myeloid leukemia | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASTX029-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06113289 ↗ |
| Route | Oral | “Given by PO” NCT06113289 ↗ |